Abstract:PurposeThe purpose of this paper is to provide a physical description of the amorphous state for pharmaceutical materials and to investigate the pharmaceutical implications. Techniques to elucidate structural differences in pharmaceutical solids exhibiting characteristic X-ray amorphous powder patterns are also presented.Materials and MethodsThe X-ray amorphous powder diffraction patterns of microcrystalline cellulose, indomethacin, and piroxicam were measured with laboratory XRPD instrumentation. Analysis of the data were carried out using a combination of direct methods, such as pair distribution functions (PDF), and indirect material modeling techniques including Rietveld, total scattering, and amorphous packing.ResultsThe observation of X-ray amorphous powder patterns may indicate the presence of amorphous, glassy or disordered nanocrystalline material in the sample. Rietveld modeling of microcrystalline cellulose (Avicel® PH102) indicates that it is predominantly disordered crystalline cellulose Form Iβ with some amorphous contribution. The average crystallite size of the disordered nanocrystalline cellulose was determined to be 10.9 nm. Total scattering modeling of ground samples of α, γ, and δ crystal forms of indomethacin in combination with analysis of the PDFs provided a quantitative picture of the local structure during various stages of grinding. For all three polymorphs, with increased grinding time, a two-phase system, consisting of amorphous and crystalline material, continually transformed to a completely random close packed (RCP) amorphous structure. The same pattern of transformation was detected for the Form I polymorph of piroxicam. However, grinding of Form II of piroxicam initially produced a disordered phase that maintained the local packing of Form II but over a very short nanometer length scale. The initial disordered phase is consistent with continuous random network (CRN) glass material. This initial disordered phase was maintained to a critical point when a transition to a completely amorphous RCP structure occurred.ConclusionsTreating X-ray amorphous powder patterns with different solid-state models, ranging from disordered nanocrystalline to glassy and amorphous, resulted in the assignment of structures in each of the systems examined. The pharmaceutical implications with respect to the stability of the solid are discussed.

Using Singular Value Decomposition to Analyze Drug /β-Cyclodextrin Mixtures: Insights from X-ray Powder Diffraction Patterns

Theoretical studies on the binding affinities of β -cyclodextrin to small molecules and monosaccharides

Using X-ray Diffraction Techniques for Biomimetic Drug Development, Formulation, and Polymorphic Characterization

Quantification of Pharmaceutical Compounds Based on Powder X-Ray Diffraction with Chemometrics

Structural analysis of pharmaceutical tablets using two-dimensional X-ray absorption fine-structure spectroscopy and its combination with X-ray computed tomography

Cyclodextrins: Establishing Building Blocks for AI-Driven Drug Design by Determining Affinity Constants in Silico

Mass Spectrometry And Molecular Modeling Studies On The Inclusion Complexes Between Alpha,Beta-Cyclodextrins And Simvastatin

Structural Interpretation in Composite Systems Using Powder X-ray Diffraction: Applications of Error Propagation to the Pair Distribution Function

Comparison of Univariate and Multivariate Models of 13C SSNMR and XRPD Techniques for Quantification of Nimodipine Polymorphs

Effect of Cyclodextrin Complex Formation on Solubility Changes of Each Drug Due to Intermolecular Interactions between Acidic NSAIDs and Basic H2 Blockers

Prediction of Dissolution Profiles from Process Parameters, Formulation and Spectroscopic Measurements.

Quantitative determination of polymorphic composition in intact compacts by parallel-beam X-ray powder diffractometry.

Evaluation of the interaction between β-cyclodextrin and psychotropic drugs by surface plasmon resonance assay with a Biacore ® system

Analysis of Amorphous and Nanocrystalline Solids from Their X-Ray Diffraction Patterns

Anomalous Properties of Cyclodextrins and Their Complexes in Aqueous Solutions

Structural Characterization of Pharmaceutical Cocrystals with the Use of Laboratory X-ray Powder Diffraction Patterns

Application of Molecular Dynamics Simulations in the Analysis of Cyclodextrin Complexes

From formulation to structure: 3D electron diffraction for the structure solution of a new indomethacin polymorph from an amorphous solid dispersion

Structural characterisation of amorphous solid dispersions via metropolis matrix factorisation of pair distribution function data

Effects of Heat Treatment on Indomethacin-Cimetidine Mixture; Investigation of Drug-Drug Interaction Using Singular Value Decomposition in FTIR Spectroscopy